Literature DB >> 30042416

Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a.

Xiaojia Huang1, Xinhua Xie1, Peng Liu1, Lu Yang1, Bo Chen1, Cailu Song1, Hailin Tang2, Xiaoming Xie3.   

Abstract

Long non-coding RNAs (lncRNAs) are reported to play vital roles in the progress of multiple cancers. However, the functions of lncRNAs in breast cancer remain to be discovered. We performed microarrays to identify the differentially expressed mRNAs and lncRNAs in breast tissues with or without miR-34a knockout. To explore the functions of the differentially expressed mRNA and lncRNA in breast cancer, we conducted a series of experiments. We found that Adam12 and lnc015192 were significantly upregulated in miR-34a knockout breast tissues. Knockdown of Adam12 and lnc015192 inhibited breast cancer cell migration, invasion, and epithelial-mesenchymal transition (EMT). Further experiments revealed that lnc015192 regulated Adam12 expression by functioning as a competing endogenous RNA (ceRNA) for miR-34a. In summary, our study demonstrate that Adam12 and lnc015192 promote breast cancer metastasis partly by sponging miR-34a through the ceRNA mechanism.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30042416     DOI: 10.1038/s41388-018-0410-1

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

Authors:  Jason F Wiggins; Lynnsie Ruffino; Kevin Kelnar; Michael Omotola; Lubna Patrawala; David Brown; Andreas G Bader
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

Review 2.  Long noncoding RNAs: cellular address codes in development and disease.

Authors:  Pedro J Batista; Howard Y Chang
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

Review 3.  The multilayered complexity of ceRNA crosstalk and competition.

Authors:  Yvonne Tay; John Rinn; Pier Paolo Pandolfi
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

4.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Authors:  Tsung-Cheng Chang; Erik A Wentzel; Oliver A Kent; Kalyani Ramachandran; Michael Mullendore; Kwang Hyuck Lee; Georg Feldmann; Munekazu Yamakuchi; Marcella Ferlito; Charles J Lowenstein; Dan E Arking; Michael A Beer; Anirban Maitra; Joshua T Mendell
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

5.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

6.  A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.

Authors:  V H Rao; A Kandel; D Lynch; Z Pena; N Marwaha; C Deng; P Watson; L A Hansen
Journal:  Oncogene       Date:  2011-10-10       Impact factor: 9.867

7.  miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

Authors:  Jing Y Krzeszinski; Wei Wei; HoangDinh Huynh; Zixue Jin; Xunde Wang; Tsung-Cheng Chang; Xian-Jin Xie; Lin He; Lingegowda S Mangala; Gabriel Lopez-Berestein; Anil K Sood; Joshua T Mendell; Yihong Wan
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

8.  A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression.

Authors:  Simon Grelet; Laura A Link; Breege Howley; Clémence Obellianne; Viswanathan Palanisamy; Vamsi K Gangaraju; J Alan Diehl; Philip H Howe
Journal:  Nat Cell Biol       Date:  2017-08-21       Impact factor: 28.824

9.  Long non-coding RNA TUG1 promotes endometrial cancer development via inhibiting miR-299 and miR-34a-5p.

Authors:  Lifen Liu; Xin Chen; Ying Zhang; Yanrong Hu; Xiaoqing Shen; Weipei Zhu
Journal:  Oncotarget       Date:  2017-05-09

10.  CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model.

Authors:  Liguo Wang; Hyun Jung Park; Surendra Dasari; Shengqin Wang; Jean-Pierre Kocher; Wei Li
Journal:  Nucleic Acids Res       Date:  2013-01-17       Impact factor: 16.971

View more
  19 in total

Review 1.  The comprehensive landscape of miR-34a in cancer research.

Authors:  Sijing Li; Xiaohui Wei; Jinyong He; Quanquan Cao; Danyu Du; Xiaoman Zhan; Yuqi Zeng; Shengtao Yuan; Li Sun
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

2.  TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p.

Authors:  Wei Song; Chuqian Zheng; Min Liu; Ying Xu; Yanyan Qian; Zhihong Zhang; Hongmeng Su; Xinxiu Li; Huazhang Wu; Pihai Gong; Yiping Li; Hong Fan
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 12.910

3.  Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.

Authors:  Xianfu Sun; Tao Huang; Chengjuan Zhang; Shengze Zhang; Yingjie Wang; Qiang Zhang; Zhenzhen Liu
Journal:  Cell Cycle       Date:  2019-06-29       Impact factor: 5.173

4.  Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development.

Authors:  Weimin Ren; Wencai Guan; Jinguo Zhang; Fanchen Wang; Guoxiong Xu
Journal:  Aging (Albany NY)       Date:  2019-04-14       Impact factor: 5.682

5.  Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer.

Authors:  Shaoquan Zheng; Lu Yang; Yutian Zou; Jie-Ying Liang; Peng Liu; Guanfeng Gao; Anli Yang; Hailin Tang; Xiaoming Xie
Journal:  J Hematol Oncol       Date:  2020-03-05       Impact factor: 17.388

6.  c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma.

Authors:  Pie-Che Chen; Chih-Chia Yu; Wen-Yu Huang; Wan-Hong Huang; Yu-Ming Chuang; Ru-Inn Lin; Jora M J Lin; Hon-Yi Lin; Yeong-Chin Jou; Cheng-Huang Shen; Michael W Y Chan
Journal:  Cancers (Basel)       Date:  2019-09-28       Impact factor: 6.639

7.  LncRNA SNHG15: A new budding star in human cancers.

Authors:  You Shuai; Zhonghua Ma; Jianwei Lu; Jifeng Feng
Journal:  Cell Prolif       Date:  2019-11-27       Impact factor: 6.831

8.  A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer.

Authors:  Xue Kong; Juan Li; Yanru Li; Weili Duan; Qiuchen Qi; Tiantian Wang; Qifeng Yang; Lutao Du; Haiting Mao; Chuanxin Wang
Journal:  Cell Death Dis       Date:  2021-07-03       Impact factor: 8.469

Review 9.  The roles of long noncoding RNAs in breast cancer metastasis.

Authors:  Lingxia Liu; Yu Zhang; Jun Lu
Journal:  Cell Death Dis       Date:  2020-09-14       Impact factor: 8.469

10.  Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.

Authors:  Chong Lu; Xiuhua Wang; Xiangwang Zhao; Yue Xin; Chunping Liu
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.